![Kenneth Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kelley
Director Ejecutivo en
IDBiologics, Inc.
.
Perfil
Kenneth J. Kelley es un empresario que fundó IntraBiotics Pharmaceuticals, Inc. y Emergent Travel Health, Inc. y que ha estado al frente de 7 empresas diferentes. En la actualidad, ocupa el cargo de presidente de Seromyx Systems, Inc. y de presidente de Selva Therapeutics, Inc. El Sr. Kelley también forma parte del consejo de Halozyme Therapeutics, Inc. (ex presidente), Meissa Vaccines, Inc., Actym Therapeutics, Inc. e IDBiologics, Inc. y director general de K2 BioVentures LLC. En su anterior carrera, Kenneth J. Kelley fue director de Solus Biosystems, Inc, presidente de Fluxion Biosciences, Inc, socio general de Latterell Venture Partners, asociado de Institutional Venture Partners, consultor de McKinsey & Co, Inc, presidente y director general de IntraBiotics Pharmaceuticals, Inc, director de Emergent Travel Health, Inc y científico de Integrated Genetics, Inc. Kenneth J. Kelley se licenció en la Universidad de Harvard y obtuvo un MBA en la Universidad de Stanford.
Cargos activos de Kenneth Kelley
| Empresas | Cargo | Inicio |
|---|---|---|
K2 BioVentures LLC | Corporate Officer/Principal | 07/07/2010 |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Director/Miembro de la Junta | 27/03/2019 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Director/Miembro de la Junta | - |
IDBiologics, Inc.
 IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Director Ejecutivo | 01/01/2017 |
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Presidente | - |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Presidente | - |
Antiguos cargos conocidos de Kenneth Kelley.
| Empresas | Cargo | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Presidente | 01/01/2015 |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Corporate Officer/Principal | 01/06/2004 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Director/Miembro de la Junta | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Kenneth Kelley.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
51
Relaciones de 1er grado
19
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 19 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Finance |
Solus Biosystems, Inc.
 Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops tools for measurement of changes in protein conformation | Electronic Technology |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Fluxion Biosciences, Inc.
 Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Provides automated patch clamp technology and cell-based assay tools | Technology Services |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
K2 BioVentures LLC | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Health Technology |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Health Technology |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Health Technology |
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Health Technology |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Health Technology |
- Bolsa de valores
- Insiders
- Kenneth Kelley
Elige MarketScreener 
